Insights into the Base-pairing Preferences of 8-oxoguanosine on the Ribosome
Overview
Affiliations
Of the four bases, guanine is the most susceptible to oxidation, which results in the formation of 8-oxoguanine (8-oxoG). In protein-free DNA, 8-oxodG adopts the syn conformation more frequently than the anti one. In the syn conformation, 8-oxodG base pairs with dA. The equilibrium between the anti and syn conformations of the adduct are known to be altered by the enzyme recognizing 8-oxodG. We previously showed that 8-oxoG in mRNA severely disrupts tRNA selection, but the underlying mechanism for these effects was not addressed. Here, we use miscoding antibiotics and ribosome mutants to probe how 8-oxoG interacts with the tRNA anticodon in the decoding center. Addition of antibiotics and introduction of error-inducing mutations partially suppressed the effects of 8-oxoG. Under these conditions, rates and/or endpoints of peptide-bond formation for the cognate (8-oxoG•C) and near-cognate (8-oxoG•A) aminoacyl-tRNAs increased. In contrast, the antibiotics had little effect on other mismatches, suggesting that the lesion restricts the nucleotide from forming other interactions. Our findings suggest that 8-oxoG predominantly adopts the syn conformation in the A site. However, its ability to base pair with adenosine in this conformation is not sufficient to promote the necessary structural changes for tRNA selection to proceed.
Miller L, Kim W, Schowe S, Taylor K, Han R, Jain V Proc Natl Acad Sci U S A. 2024; 121(46):e2317865121.
PMID: 39495922 PMC: 11572968. DOI: 10.1073/pnas.2317865121.
Specific prediction of mortality by oxidative stress-induced damage to RNA vs. DNA in humans.
Jorgensen A, Brandslund I, Ellervik C, Henriksen T, Weimann A, Andersen P Aging Cell. 2023; 22(6):e13839.
PMID: 37190886 PMC: 10265158. DOI: 10.1111/acel.13839.
Methylated guanosine and uridine modifications in mRNAs modulate translation elongation.
Jones J, Franco M, Smith T, Snyder L, Anders A, Ruotolo B RSC Chem Biol. 2023; 4(5):363-378.
PMID: 37181630 PMC: 10170649. DOI: 10.1039/d2cb00229a.
Lenz M, Eichler A, Kruse P, Stohr P, Kleidonas D, Galanis C Front Mol Neurosci. 2023; 16:1148219.
PMID: 37122623 PMC: 10130538. DOI: 10.3389/fnmol.2023.1148219.
8-Oxoguanine: from oxidative damage to epigenetic and epitranscriptional modification.
Hahm J, Park J, Jang E, Chi S Exp Mol Med. 2022; 54(10):1626-1642.
PMID: 36266447 PMC: 9636213. DOI: 10.1038/s12276-022-00822-z.